JPMorgan Downgrades HP Stock: What Investors Need to Know
JPMorgan cuts HP Inc. rating to Neutral as PC replacement cycle ends and growth challenges emerge.
Already have an account? Sign in.
JPMorgan cuts HP Inc. rating to Neutral as PC replacement cycle ends and growth challenges emerge.
Mineralys receives FDA acceptance of NDA for lorundrostat for hypertension. PDUFA target date: December 22, 2026. Explore-OSA missed primary endpoint but demonstrated meaningful BP reduction.
Joby, Archer, and Beta stocks surge after DOT selects them for Trump's eVTOL air taxi pilot program — electric flying taxis set to test in 26 states starting summer 2026.
Vertex Pharmaceuticals' povetacicept succeeds in Phase 3 RAINIER trial for IgA nephropathy with 52% proteinuria reduction. Positive safety data and FDA submission planned soon.